Biotech Investing: World

Coverage of the biotech market for global investors, including news, analysis forecasts, and stock updates.

Transparent blue cells with dark centers floating against a vibrant blue background.

Biotech and Pharma Market Update: Q1 2026 in Review

Explore Q1 biotech and pharma market trends, focusing on innovation, NIH funding and the evolving role of AI in life sciences.

Life Science Investing
Latest Articles

Kailera, Alamar Target Billion-Dollar Valuations in Biotech Revival

Biotech Investing

Anthropic Inks US$400 Million Deal for AI Biotech Startup Coefficient Bio

Biotech Investing

Moderna to Pay US$950 Million to Settle COVID-19 Vaccine Patent Dispute

Pharmaceutical Investing

5 Small-cap Biotech ETFs to Watch

Biotech Investing

Top 5 Small-cap Biotech Stocks

Biotech Investing

Top 4 Canadian Biotech Stocks

Biotech Investing
Company Profiles
More Companies
CEO Interviews
Badge
Invion Limited
Revolutionizing Photodynamic Therapy (PDT) for cancer and infectious diseases
SPONSORED/ Invion Limited

Invion Advances Global Strategy With New Licencing Agreement

Pharmaceutical Investing
Badge
Invion Limited
Revolutionizing Photodynamic Therapy (PDT) for cancer and infectious diseases
SPONSORED/ Invion Limited

New Deal Could Spark Invion’s Entry into Pet Cancer Market, CEO Says

Pharmaceutical Investing
Badge
Invion Limited
Revolutionizing Photodynamic Therapy (PDT) for cancer and infectious diseases
SPONSORED/ Invion Limited

Invion CEO Maps Path to Peer-level Valuation as Momentum for Cancer Treatment Trials Builds

Pharmaceutical Investing
biotech News
Lexaria Bioscience (NASDAQ:LEXX)

Lexaria Applauds Eli Lilly's Foundayo Drug Approval

Biotech Investing
Lexaria Bioscience (NASDAQ:LEXX)

Lexaria Applauds Eli Lilly's Foundayo Drug Approval

Biotech Investing
Lexaria Bioscience (NASDAQ:LEXX)

Lexaria to Begin New Human Clinical Study in GLP-1

Life Science Investing
Solvonis Therapeutics (LSE:SVNS)

SVN-114 selected as the lead candidate for PTSD discovery programme

Psychedelics Investing
Cardiol Therapeutics (TSX:CRDL)

Cardiol Therapeutics to Present at TD Cowen 46th Annual Health Care Conference

Biotech Investing
Cardiol Therapeutics (TSX:CRDL)

Cardiol Therapeutics' ARCHER Phase II Study Results Published in ESC Heart Failure

Biotech Investing
Seegnal (TSXV:SEGN)

Seegnal Expands Deployment of Seegnal's Prescription Intelligence Platform at Tel Aviv Sourasky Medical Center, a Leading Israeli Public Medical Center and Global Referral Center

Biotech Investing
Solvonis Therapeutics (LSE:SVNS)

Expansion of SVN-015 into Depression Following Positive Preclinical Data

Pharmaceutical Investing
Cardiol Therapeutics (TSX:CRDL)

Cardiol Therapeutics Announces Closing of Bought Deal Financing and Full Exercise of Over-Allotment Option for Gross Proceeds of $14.85 Million

Biotech Investing
Cardiol Therapeutics (TSX:CRDL)

Cardiol Therapeutics Announces Bought Deal Financing for Gross Proceeds of $13.5 Million

Biotech Investing
Cardiol Therapeutics (TSX:CRDL)

Cardiol Therapeutics Inc. Announces Bought Deal Financing for Gross Proceeds of $13.5 Million

Biotech Investing
Cardiol Therapeutics (TSX:CRDL)

Cardiol Therapeutics Achieves Key 50% Patient Enrollment Milestone in Pivotal Phase III MAVERIC Trial in Recurrent Pericarditis

Biotech Investing
Invion Limited (ASX:IVX)

Hanlim & Korean Government Fund Pathway to Clinical Trial

Pharmaceutical Investing
Invion Limited (ASX:IVX)

Invion Secures Expanded Photosoft Global Exclusive License

Pharmaceutical Investing
Nextech3D.ai (CSE:NTAR)

Nextech3D.ai Announces Definitive Agreement to Acquire 100% of ARway, Streamlining Operations

Artificial Intelligence Investing
More biotech News
Editors' Picks
Biotech Investing

Biotech Market Forecast: Top Trends for Biotech in 2026

Life Science Investing

Biotech and Pharma Market Update: Q3 2025 in Review

Life Science Investing

Biotech and Pharma Market Update: Q2 2025 in Review

Latest biotech News

More biotech News

Outlook Reports

Resource
Tech
Life Science

Browse Companies

Resource
Tech
Life Science
MARKETS
COMMODITIES
CURRENCIES